Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Indian J Exp Biol ; 49(9): 645-53, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21941936

ABSTRACT

Expressing proteins of interest as fusion to proteins of bacterial envelope is a powerful technique for biotechnological and medical applications. The synthetic gene (VacII) encoding for T-cell epitopes of selected genes of Mycobacterium tuberculosis namely, ESAT6, MTP40, 38 kDa, and MPT64 was fused with N- terminus of Pseudomonas syringae ice nucleation protein (INP) outer membrane protein. The fused genes were cloned into a bacterial expression vector pKK223-3. The recombinant protein was purified by Ni-NAT column. VacII gene was displayed on the cell surface of Salmonella typhi Ty21a using N-terminal region of ice nucleation proteins (INP) as an anchoring motif. Glycine method confirmed that VacII was anchored on the cell surface. Western blot analysis further identified the synthesis of INP derivatives containing the N-terminal domain INP- VacII fusion protein of the expected size (52 kDa).


Subject(s)
Antigens, Bacterial/genetics , Biotechnology/methods , Epitopes, T-Lymphocyte/genetics , Recombinant Fusion Proteins/biosynthesis , Salmonella typhi/genetics , Antigens, Bacterial/chemistry , Antigens, Bacterial/immunology , Bacterial Outer Membrane Proteins/genetics , Base Sequence , Blotting, Western , Cloning, Molecular , Electrophoresis, Polyacrylamide Gel , Epitopes, T-Lymphocyte/chemistry , Gene Expression , Genes, Synthetic , Molecular Sequence Data , Plasmids , Polymerase Chain Reaction , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/isolation & purification , Salmonella typhi/metabolism
2.
Histol Histopathol ; 24(5): 559-65, 2009 05.
Article in English | MEDLINE | ID: mdl-19283664

ABSTRACT

Vibrio cholerae is the causative agent of the infectious disease, cholera. The bacteria adhere to the mucosal membrane and release cholera toxin, leading to watery diarrhea. There are >100 serovars of V. cholerae, but the O1 and O139 serovars are the main causative agents of cholera. The present study aimed to compare the severity of intestinal mucosal infection caused by O1 El Tor and O139 V. cholerae in a rabbit ileal loop model. The results showed that although the fluid accumulation was similar in the loops inoculated with O1 and O139 V. cholerae, the presence of blood was detected only in the loops inoculated with the O139 serovar. Serosal hemorrhage was confirmed by histopathological examination and the loops inoculated with O139 showed massive destruction of villi and loss of intestinal glands. The submucosa and muscularis mucosa of the ileum showed the presence of edema with congested blood vessels, while severe hemorrhage was seen in the muscularis propria layer. The loops inoculated with O1 El Tor showed only minimal damage, with intact intestinal villi and glands. Diffuse colonies of the O139 serovar were seen to have infiltrated deep into the submucosal layer of the intestine. Although the infection caused by the O1 serovar was focal and invasive, it was more superficial than that due to O139, and involved only the villi. These observations were confirmed by immunostaining with O1 and O139 V. cholerae-specific monoclonal antibodies. The peroxidase reaction demonstrated involvement of tissues down to the submucosal layer in O139 V. cholerae infection, while in O1 El Tor infection, the reaction was confined mainly to the villi, and was greatly reduced in the submucosal region. This is the first reported study to clearly demonstrate the histopathological differences between infections caused by the O139 Bengal and O1 El Tor pathogenic serovars of V. cholerae.


Subject(s)
Cholera/microbiology , Cholera/pathology , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Vibrio cholerae O139/pathogenicity , Vibrio cholerae O1/pathogenicity , Animals , Disease Models, Animal , Enterocytes/pathology , Ileum/microbiology , Ileum/pathology , Immunoenzyme Techniques , Mucous Membrane/pathology , Rabbits , Species Specificity , Virulence
3.
J Microbiol Methods ; 75(1): 142-4, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18579241

ABSTRACT

A PCR assay has been developed based on a lolB (hemM) gene, which was found to be highly conserved among the Vibrio cholerae species but non-conserved among the other enteric bacteria. The lolB PCR detected all O1, O139 and non-O1/non-O139 serogroup and biotypes of V. cholerae. The analytical specificity of this assay was 100% while the analytical sensitivity was 10 pg/microL and 10(3) CFU/mL at DNA and bacterial level respectively. The diagnostic sensitivity and specificity was 98.5% and 100% respectively.


Subject(s)
Bacterial Proteins/genetics , Coproporphyrinogen Oxidase/genetics , Polymerase Chain Reaction/methods , Vibrio Infections/microbiology , Vibrio cholerae/genetics , Vibrio cholerae/isolation & purification , DNA, Bacterial/genetics , Gram-Negative Bacteria/genetics , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Humans , Sensitivity and Specificity
4.
BMC Ophthalmol ; 8: 7, 2008 Apr 29.
Article in English | MEDLINE | ID: mdl-18445283

ABSTRACT

BACKGROUND: The sensitivity and specificity of 18S rRNA polymerase chain reaction (PCR) in the detection of fungal aetiology of microbial keratitis was determined in thirty patients with clinical diagnosis of microbial keratitis. METHODS: Corneal scrapings from patients were used for Gram stain, culture and PCR analysis. PCR was performed with primer pairs targeted to the 18S rRNA gene. The result of the PCR was compared with conventional culture and Gram staining method. The PCR positive samples were identified by DNA sequencing of the internal transcribed spacer (ITS) region of the rRNA gene. Main outcome measures were sensitivity and specificity of PCR in the detection of fungus in corneal keratitis. RESULTS: Combination of microscopy and culture gave a positive result in 11 of 30 samples of microbial keratitis. PCR detected 10 of 11 samples that were positive by conventional method. One of the 19 samples that was negative by conventional method was positive by PCR. Statistical analysis revealed that the PCR to have a sensitivity of 90.9% and specificity of 94.7% in the detection of a fungal aetiology in microbial keratitis. CONCLUSION: PCR is a rapid, sensitive and useful method to detect fungal aetiology in microbial keratitis.


Subject(s)
Cornea/microbiology , Eye Infections, Fungal/diagnosis , Fungi/genetics , Keratitis/microbiology , Polymerase Chain Reaction/methods , RNA, Ribosomal, 18S/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , DNA, Fungal , Female , Humans , Keratitis/pathology , Male , Middle Aged , Polymerase Chain Reaction/standards , Sensitivity and Specificity , Sequence Analysis , Time Factors
5.
Protein Expr Purif ; 47(2): 341-7, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16510294

ABSTRACT

Tuberculosis remains a major infectious disease with over 8 million new cases and 2 million deaths annually. Therefore, a vaccine more potent than BCG is desperately needed. In this regard, an approximately 800 bp DNA encoding a mycobacterial synthetic gene designated as VacIII (containing ubiquitin gene UbGR and four immunogenic mycobacterial epitopes or genes of ESAT-6, Phos1, Hsp 16.3, and Mtb8.4) was sub-cloned into a bacterial expression vector of pRSET-B resulting in a 6 x His-VacIII fusion gene construction. This recombinant clone was over expressed in Escherichia coli BL-21 (DE-3). The expressed fusion protein was found almost entirely in the insoluble form (inclusion bodies) in cell lysate. The inclusion bodies were solubilized with 8M urea and the recombinant protein was purified by Ni-NTA column and dialyzed by urea gradient dialysis. This method produced a relatively high yield of recombinant VacIII protein and the cloned VacIII gene offers the potential development of other vaccine formats such as DNA vaccine and recombinant vaccine.


Subject(s)
Antigens, Bacterial/biosynthesis , Mycobacterium tuberculosis/genetics , Recombinant Fusion Proteins/biosynthesis , Tuberculosis Vaccines/biosynthesis , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , Antigens, Bacterial/isolation & purification , Cloning, Molecular , Escherichia coli/genetics , Gene Expression , Intranuclear Inclusion Bodies/immunology , Intranuclear Inclusion Bodies/metabolism , Mycobacterium tuberculosis/immunology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/isolation & purification , Tuberculosis Vaccines/genetics , Tuberculosis Vaccines/immunology , Tuberculosis Vaccines/isolation & purification , Vaccines, Acellular/biosynthesis , Vaccines, Acellular/genetics , Vaccines, Acellular/immunology , Vaccines, Acellular/isolation & purification
6.
Vaccine ; 24(18): 3750-61, 2006 May 01.
Article in English | MEDLINE | ID: mdl-16102875

ABSTRACT

In this paper, we describe the development of VCUSM2, a live metabolic auxotroph of Vibrio cholerae O139. Auxotrophy was achieved by mutating a house keeping gene, hemA, that encodes for glutamyl-tRNA reductase, an important enzyme in the C5 pathway for delta-aminolevulenic acid (ALA) biosynthesis, which renders this strain dependent on exogenous ALA for survival. Experiments using the infant mouse and adult rabbit models show that VCUSM2 is a good colonizer of the small intestine and elicits greater than a four-fold rise in vibriocidal antibodies in vaccinated rabbits. Rabbits vaccinated with VCUSM2 were fully protected against subsequent challenge with 1 x 10(11) CFU of the virulent wild type (WT) strain. Experiments using ligated ileal loops of rabbits show that VCUSM2 is 2.5-fold less toxic at the dose of 1 x 10(6) CFU compared to the WT strain. Shedding of VCUSM2 in rabbits were found to occur for no longer than 4 days and its maximum survival rate in environmental waters is 8 days compared to the greater than 20 days for the WT strain. VCUSM2 is thus a potential vaccine candidate against infection by V. cholerae O139.


Subject(s)
Aldehyde Oxidoreductases/genetics , Cholera Vaccines/immunology , Cholera/prevention & control , Vaccines, Attenuated/immunology , Vibrio cholerae O139/immunology , Animals , Antibodies, Bacterial/blood , Cholera Toxin/immunology , Cholera Vaccines/administration & dosage , Cholera Vaccines/genetics , Colony Count, Microbial , Disease Models, Animal , Immunoglobulin A/blood , Immunoglobulin G/blood , Intestine, Small/microbiology , Lipopolysaccharides/immunology , Mice , Mice, Inbred BALB C , Mutation , Rabbits , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/genetics , Vibrio cholerae O139/genetics , Vibrio cholerae O139/growth & development , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...